| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113762.1.4.1116.59 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.59 |
| version | 20220428 |
| status | active |
| publisher | CancerLinQ Steward |
| name | TrastuzumabAdministration |
| title | Trastuzumab Administration |
| date | 2022-04-28T01:02:36-04:00 |
| experimental | false |
| Usages | (none) |
This value set contains 44 concepts
| Code | System | Display |
| 101306 | http://www.nlm.nih.gov/research/umls/rxnorm | Herceptin |
| 1162762 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab Injectable Product |
| 1169113 | http://www.nlm.nih.gov/research/umls/rxnorm | Herceptin Injectable Product |
| 1371041 | http://www.nlm.nih.gov/research/umls/rxnorm | ado-trastuzumab emtansine |
| 1371046 | http://www.nlm.nih.gov/research/umls/rxnorm | KADCYLA |
| 1371049 | http://www.nlm.nih.gov/research/umls/rxnorm | KADCYLA Injectable Product |
| 1658084 | http://www.nlm.nih.gov/research/umls/rxnorm | ado-trastuzumab emtansine 100 MG Injection |
| 1658087 | http://www.nlm.nih.gov/research/umls/rxnorm | ado-trastuzumab emtansine 100 MG Injection [KADCYLA] |
| 1658089 | http://www.nlm.nih.gov/research/umls/rxnorm | ado-trastuzumab emtansine 160 MG Injection |
| 1658091 | http://www.nlm.nih.gov/research/umls/rxnorm | ado-trastuzumab emtansine 160 MG Injection [KADCYLA] |
| 1922509 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab 150 MG Injection |
| 1922516 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab 21 MG/ML Injectable Solution |
| 2103478 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-dkst |
| 2107051 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-pkrb |
| 2107053 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-pkrb 21 MG/ML Injectable Solution |
| 2119714 | http://www.nlm.nih.gov/research/umls/rxnorm | 5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection |
| 2169359 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-pkrb 150 MG Injection |
| 2174802 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-anns |
| 2174804 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-anns 21 MG/ML Injectable Solution |
| 2179753 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-dkst 150 MG Injection |
| 2179760 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-dkst 21 MG/ML Injectable Solution |
| 224905 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab |
| 2257297 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-anns 150 MG Injection |
| 2267574 | http://www.nlm.nih.gov/research/umls/rxnorm | fam-trastuzumab deruxtecan-nxki |
| 2267576 | http://www.nlm.nih.gov/research/umls/rxnorm | fam-trastuzumab deruxtecan-nxki 100 MG Injection |
| 2267582 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab deruxtecan |
| 2280730 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-qyyp |
| 2280732 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-qyyp 21 MG/ML Injectable Solution |
| 2289225 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-dttb |
| 2289227 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-dttb 150 MG Injection |
| 2289234 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-dttb 21 MG/ML Injectable Solution |
| 2382603 | http://www.nlm.nih.gov/research/umls/rxnorm | hyaluronidase / pertuzumab / trastuzumab |
| 2382604 | http://www.nlm.nih.gov/research/umls/rxnorm | 15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection |
| 2383305 | http://www.nlm.nih.gov/research/umls/rxnorm | 10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection |
| 2472791 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab-qyyp 150 MG Injection |
| 327397006 | http://snomed.info/sct | Product containing trastuzumab (medicinal product) |
| 327399009 | http://snomed.info/sct | Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| 375356000 | http://snomed.info/sct | Product containing precisely trastuzumab 440 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| 377216 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab Injectable Solution |
| 387003001 | http://snomed.info/sct | Trastuzumab (substance) |
| 540885 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab Injectable Solution [Herceptin] |
| 702836004 | http://snomed.info/sct | Trastuzumab emtansine (substance) |
| 806572 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab 22 MG/ML |
| 806573 | http://www.nlm.nih.gov/research/umls/rxnorm | trastuzumab 22 MG/ML Injectable Solution |
Produced 08 Sep 2023